Large-scale testing (Phase 3)UnknownNCT02893540What this trial is testingMetronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRCWho this might be right forColorectal Cancer Ruijin Hospital 250
Not applicableStudy completedNCT01039506What this trial is testingAn Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)Who this might be right forMetastatic Colorectal Cancer Daiichi Sankyo Co., Ltd. 1,376
Testing effectiveness (Phase 2)Study completedNCT02278133What this trial is testingStudy of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway MutationsWho this might be right forMetastatic Colorectal Cancer Array BioPharma 20
Large-scale testing (Phase 3)UnknownNCT03389659What this trial is testingXELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRCWho this might be right forVitamin D3 Tianjin Medical University Cancer Institute and Hospital 750
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Not applicableStudy completedNCT02256800What this trial is testingEscalated Dose of Irinotecan in mCRCWho this might be right forMetastatic Colorectal Cancer Jaw-Yuan Wang, MD, PhD 213
Testing effectiveness (Phase 2)UnknownNCT05970302What this trial is testingXELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRCWho this might be right forTislelizumabBevacizumabOxaliplatin+5 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Testing effectiveness (Phase 2)UnknownNCT03792269What this trial is testingIntraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRCWho this might be right forColorectal Cancer MetastaticChemotherapy EffectChemotherapeutic Toxicity The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239What this trial is testingQL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Study completedNCT02835924What this trial is testingStudy Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRCWho this might be right forMetastatic Colorectal Cancer Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 299
Testing effectiveness (Phase 2)Looking for participantsNCT06643793What this trial is testingEvaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRCWho this might be right forColorectal Neoplasms Malignant Affiliated Hospital of Nantong University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04730544What this trial is testingTwo Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.Who this might be right forColorectal Cancer MetastaticMSI-H Colorectal Cancer GERCOR - Multidisciplinary Oncology Cooperative Group 96
Testing effectiveness (Phase 2)WithdrawnNCT05690035What this trial is testingTislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal CancerWho this might be right forMetastatic Colorectal CancermCRC Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT01875380What this trial is testingRegorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal CancerWho this might be right forColorectal NeoplasmsMetastatic Disease Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 46
Large-scale testing (Phase 3)WithdrawnNCT01786538What this trial is testingSecond-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus FluoropyrimidinesWho this might be right forMetastatic Colorectal Cancer Asan Medical Center
Testing effectiveness (Phase 2)Study completedNCT00125034What this trial is testingOxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)Who this might be right forNeoplasm MetastasisColorectal Cancer Merck KGaA, Darmstadt, Germany 344
Not applicableUnknownNCT04831528What this trial is testingDecision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical StudyWho this might be right forMetastatic Colorectal Cancer Fudan University 100
Testing effectiveness (Phase 2)Ended earlyNCT05330429What this trial is testingStudy of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)Who this might be right forMetastatic Colorectal Cancer Gilead Sciences 77
Testing effectiveness (Phase 2)Study completedNCT01008475What this trial is testingEMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Merck KGaA, Darmstadt, Germany 232
Large-scale testing (Phase 3)Not Yet RecruitingNCT06959693What this trial is testingA Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)Who this might be right forMetastatic Colorectal Cancer (CRC) Sun Yat-sen University 590